MedPath

RELISTOR

RELISTOR

Approved
DIN Number

02308215

Drug Class

Human

Market Date

May 7, 2008

Company
HC

SALIX PHARMACEUTICALS INC

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02308215
AIG Number0152456001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A06AH01 METHYLNALTREXONE BROMIDE
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification56:92.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

METHYLNALTREXONE BROMIDEActive
Strength: 20 MG / ML
Monograph: METHYLNALTREXONE BROMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.